How To Use HCPCS Code C9486

HCPCS code C9486 describes an injection of granisetron extended release, with a strength of 0.1 mg. This code is used to identify the administration of this specific medication in a healthcare setting. In this article, we will explore the details of HCPCS code C9486, including its official description, procedure, when to use it, billing guidelines, historical information, and Medicare and insurance coverage.

1. What is HCPCS C9486?

HCPCS code C9486 is a specific code used to identify the injection of granisetron extended release, with a strength of 0.1 mg. It is important to note that HCPCS codes are used for reporting medical procedures, services, and supplies to insurance companies for reimbursement purposes. This code allows healthcare providers to accurately document and bill for the administration of granisetron extended release.

2. Official Description

The official description of HCPCS code C9486 is “Injection, granisetron extended release, 0.1 mg.” This description provides a clear and concise explanation of the specific medication and dosage being administered.

3. Procedure

1. Prepare the injection site according to standard aseptic techniques.
2. Draw up the appropriate dosage of granisetron extended release into a syringe.
3. Administer the injection using the appropriate route (e.g., intramuscular, subcutaneous, etc.) as determined by the healthcare provider.
4. Dispose of any used needles and syringes in a sharps container.

It is important for healthcare providers to follow proper procedure and guidelines when administering HCPCS code C9486 to ensure patient safety and accurate documentation.

4. When to use HCPCS code C9486

HCPCS code C9486 should be used when administering granisetron extended release, with a strength of 0.1 mg, to a patient. This code is specific to the medication and dosage mentioned in the official description. It is important to review the patient’s medical records and consult with the healthcare provider to determine if HCPCS code C9486 is appropriate for the specific situation.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9486, healthcare providers should ensure that the following documentation is included:

• Patient’s medical records, including the reason for the administration of granisetron extended release.
• Date and time of the injection.
• Dosage and strength of the medication administered.
• Route of administration (e.g., intramuscular, subcutaneous, etc.).
• Any additional relevant information or notes regarding the administration.

It is important to accurately document and bill for the administration of HCPCS code C9486 to ensure proper reimbursement and compliance with insurance guidelines.

6. Historical Information and Code Maintenance

HCPCS code C9486 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. This code has a pricing indicator code of 57, which indicates that it is priced by other carriers. The multiple pricing indicator code for HCPCS code C9486 is A, which means it is not applicable as HCPCS priced under one methodology.

It is important to note that HCPCS code C9486 was terminated on December 31, 2017. This means that it is no longer in use for billing purposes after this date.

7. Medicare and Insurance Coverage

HCPCS code C9486 is assigned a coverage code of D, which indicates that special coverage instructions apply. This means that there may be specific eligibility criteria or guidelines for using this code, which should be reviewed and followed by healthcare providers.

Medicare and other insurance providers may have specific pricing and coverage policies for HCPCS code C9486. It is important to consult with the respective payers to determine the reimbursement rates and coverage guidelines for this code.

8. Examples

Here are five examples of when HCPCS code C9486 may be billed:

1. A patient with chemotherapy-induced nausea and vomiting receives an injection of granisetron extended release, 0.1 mg, to help alleviate their symptoms.
2. A patient undergoing radiation therapy experiences severe nausea and is administered granisetron extended release, 0.1 mg, to manage their symptoms.
3. A patient with post-operative nausea and vomiting is given an injection of granisetron extended release, 0.1 mg, to provide relief.
4. A patient with gastroenteritis is administered granisetron extended release, 0.1 mg, to help control their nausea and vomiting.
5. A patient with motion sickness is given an injection of granisetron extended release, 0.1 mg, prior to a long car journey.